speb/financial-data huggingface dataset:
SKIL balance_sheet (annual, 2026-01-31) — Other Intangible Assets: 308031000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 308031000.00
SKIL cash_flow (annual, 2026-01-31) — Other Non Cash Items: 3909000.00
SKIL cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 995000.00
SKIL balance_sheet (annual, 2026-01-31) — Other Non Current Assets: 474000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 474000.00
SKIL balance_sheet (annual, 2026-01-31) — Other Non Current Liabilities: 2085000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 2085000.00
SKIL income_statement (annual, 2026-01-31) — Other Non Operating Income Expenses: -3696000.00
SKIL income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: -1188000.00
SKIL income_statement (annual, 2026-01-31) — Other Operating Expenses: 16452000.00
SKIL income_statement (quarterly, 2026-01-31) — Other Operating Expenses: 3993000.00
SKIL balance_sheet (annual, 2026-01-31) — Other Properties: 8395000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Other Properties: 8395000.00
SKIL balance_sheet (annual, 2026-01-31) — Other Receivables: 1025000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Other Receivables: 1025000.00
SKIL income_statement (annual, 2026-01-31) — Other Taxes: 932000.00
SKIL income_statement (quarterly, 2026-01-31) — Other Taxes: 234000.00
SKIL balance_sheet (annual, 2026-01-31) — Payables: 31860000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Payables: 31860000.00
SKIL balance_sheet (annual, 2026-01-31) — Payables And Accrued Expenses: 46078000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 46078000.00
SKIL balance_sheet (annual, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 43018000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 43018000.00
SKIL balance_sheet (annual, 2026-01-31) — Prepaid Assets: 29822000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 29822000.00
SKIL income_statement (annual, 2026-01-31) — Pretax Income: -153533000.00
SKIL income_statement (quarterly, 2026-01-31) — Pretax Income: -40429000.00
SKIL cash_flow (annual, 2026-01-31) — Proceeds From Stock Option Exercised: -3250000.00
SKIL cash_flow (quarterly, 2026-01-31) — Proceeds From Stock Option Exercised: -59000.00
SKIL cash_flow (annual, 2026-01-31) — Provisionand Write Offof Assets: -119000.00
SKIL cash_flow (quarterly, 2026-01-31) — Provisionand Write Offof Assets: 6000.00
SKIL cash_flow (annual, 2026-01-31) — Purchase Of PPE: -1766000.00
SKIL cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -160000.00
SKIL balance_sheet (annual, 2026-01-31) — Receivables: 175988000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Receivables: 175988000.00
SKIL income_statement (annual, 2026-01-31) — Reconciled Cost Of Revenue: 132821000.00
SKIL income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 33769000.00
SKIL income_statement (annual, 2026-01-31) — Reconciled Depreciation: 129163000.00
SKIL income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 32680000.00
SKIL cash_flow (annual, 2026-01-31) — Repayment Of Debt: -4803000.00
SKIL cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: 0.00
SKIL cash_flow (annual, 2026-01-31) — Repurchase Of Capital Stock: 0.00
SKIL income_statement (annual, 2026-01-31) — Research And Development: 55626000.00
SKIL income_statement (quarterly, 2026-01-31) — Research And Development: 13418000.00
SKIL balance_sheet (annual, 2026-01-31) — Restricted Cash: 3662000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Restricted Cash: 3662000.00
SKIL income_statement (annual, 2026-01-31) — Restructuring And Mergern Acquisition: 18697000.00
SKIL income_statement (quarterly, 2026-01-31) — Restructuring And Mergern Acquisition: 9717000.00
SKIL balance_sheet (annual, 2026-01-31) — Retained Earnings: -1583210000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -1583210000.00
SKIL income_statement (annual, 2026-01-31) — Salaries And Wages: 169263000.00
SKIL income_statement (quarterly, 2026-01-31) — Salaries And Wages: 38672000.00
SKIL cash_flow (annual, 2026-01-31) — Sale Of PPE: 0.00
SKIL cash_flow (quarterly, 2026-01-31) — Sale Of PPE: 0.00
SKIL income_statement (annual, 2026-01-31) — Selling And Marketing Expense: 20161000.00
SKIL income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 4836000.00
SKIL income_statement (annual, 2026-01-31) — Selling General And Administration: 216760000.00
SKIL income_statement (quarterly, 2026-01-31) — Selling General And Administration: 51045000.00
SKIL balance_sheet (annual, 2026-01-31) — Share Issued: 9095922.00
SKIL balance_sheet (quarterly, 2026-01-31) — Share Issued: 9095922.00
SKIL income_statement (annual, 2026-01-31) — Special Income Charges: -50413000.00
SKIL income_statement (quarterly, 2026-01-31) — Special Income Charges: -20662000.00
SKIL cash_flow (annual, 2026-01-31) — Stock Based Compensation: 13240000.00
SKIL cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 1953000.00
SKIL balance_sheet (annual, 2026-01-31) — Stockholders Equity: -30227000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: -30227000.00
SKIL balance_sheet (annual, 2026-01-31) — Tangible Book Value: -634558000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: -634558000.00
SKIL income_statement (annual, 2026-01-31) — Tax Effect Of Unusual Items: -4818994.00
SKIL income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -1913375.77
SKIL income_statement (annual, 2026-01-31) — Tax Provision: -13709000.00
SKIL income_statement (quarterly, 2026-01-31) — Tax Provision: -3721000.00
SKIL income_statement (annual, 2026-01-31) — Tax Rate For Calcs: 0.09
SKIL income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.09
SKIL balance_sheet (annual, 2026-01-31) — Total Assets: 963118000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Assets: 963118000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Capitalization: 540542000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 540542000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Debt: 586264000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Debt: 586264000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: -30227000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: -30227000.00
SKIL income_statement (annual, 2026-01-31) — Total Expenses: 551754000.00
SKIL income_statement (quarterly, 2026-01-31) — Total Expenses: 135139000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 993345000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 993345000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Non Current Assets: 630091000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 630091000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 620345000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 620345000.00
SKIL income_statement (annual, 2026-01-31) — Total Operating Income As Reported: -89493000.00
SKIL income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: -25148000.00
SKIL balance_sheet (annual, 2026-01-31) — Total Tax Payable: 10551000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 10551000.00
SKIL income_statement (annual, 2026-01-31) — Total Unusual Items: -54146000.00
SKIL income_statement (quarterly, 2026-01-31) — Total Unusual Items: -20789000.00
SKIL income_statement (annual, 2026-01-31) — Total Unusual Items Excluding Goodwill: -54146000.00
SKIL income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -20789000.00
SKIL balance_sheet (annual, 2026-01-31) — Treasury Shares Number: 299777.00
SKIL balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 299777.00
SKIL balance_sheet (annual, 2026-01-31) — Treasury Stock: 10891000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 10891000.00
SKIL balance_sheet (annual, 2026-01-31) — Working Capital: -39973000.00
SKIL balance_sheet (quarterly, 2026-01-31) — Working Capital: -39973000.00
SKIL income_statement (quarterly, 2026-04-30) — +Operating Expense: 85567000.00
SKIL income_statement (quarterly, 2026-04-30) — +Total Revenue: 94498000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 9056000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 77313000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 1578986000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -366000.00
SKIL income_statement (quarterly, 2026-04-30) — Amortization: 29561000.00
SKIL cash_flow (quarterly, 2026-04-30) — Amortization Cash Flow: 30866000.00
SKIL cash_flow (quarterly, 2026-04-30) — Amortization Of Intangibles: 30866000.00
SKIL income_statement (quarterly, 2026-04-30) — Amortization Of Intangibles Income Statement: 29561000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Assets Held For Sale Current: 53148000.00
SKIL income_statement (quarterly, 2026-04-30) — Basic Average Shares: 8811277.00
SKIL income_statement (quarterly, 2026-04-30) — Basic EPS: -4.89
SKIL cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 104478000.00
SKIL cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -3501000.00
SKIL cash_flow (quarterly, 2026-04-30) — Capital Expenditure Reported: -3076000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Capital Stock: 1000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 115562000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 115562000.00
SKIL cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -3316000.00
SKIL cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -3501000.00
SKIL cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 28940000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Account Payable: -6107000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Accrued Expense: -21289000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: -36774000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Payable: -6107000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -27396000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: 4641000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Receivables: 80875000.00
SKIL cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 21346000.00
SKIL cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 80875000.00
SKIL cash_flow (quarterly, 2026-04-30) — Changes In Cash: 22123000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Common Stock: 1000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: -72815000.00
SKIL income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 15889000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 14587000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Assets: 287010000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Debt: 7404000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 7404000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 221299000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 221299000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 313911000.00
SKIL cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: 1385000.00
SKIL cash_flow (quarterly, 2026-04-30) — Deferred Tax: 1385000.00
SKIL cash_flow (quarterly, 2026-04-30) — Depreciation: 452000.00
SKIL cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 31318000.00
SKIL income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 29561000.00
SKIL cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 31318000.00
SKIL income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 29561000.00
SKIL income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 8811277.00
SKIL income_statement (quarterly, 2026-04-30) — Diluted EPS: -4.89
SKIL income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -43114000.00
SKIL income_statement (quarterly, 2026-04-30) — EBIT: -3903000.00
SKIL income_statement (quarterly, 2026-04-30) — EBITDA: 27415000.00
SKIL cash_flow (quarterly, 2026-04-30) — Effect Of Exchange Rate Changes: -356000.00
SKIL cash_flow (quarterly, 2026-04-30) — End Cash Position: 126245000.00
SKIL cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -3316000.00
SKIL cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 25439000.00
SKIL cash_flow (quarterly, 2026-04-30) — Gain Loss On Investment Securities: -1245000.00
SKIL cash_flow (quarterly, 2026-04-30) — Gain Loss On Sale Of PPE: 15603000.00
SKIL income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 1245000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -14587000.00
SKIL income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 35389000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Goodwill: 287650000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 546303000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 77679000.00
SKIL income_statement (quarterly, 2026-04-30) — Gross Profit: 78609000.00
SKIL cash_flow (quarterly, 2026-04-30) — Income Tax Paid Supplemental Data: 681000.00
SKIL income_statement (quarterly, 2026-04-30) — Insurance And Claims: 485000.00
SKIL income_statement (quarterly, 2026-04-30) — Interest Expense: 13748000.00
SKIL income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 13748000.00
SKIL income_statement (quarterly, 2026-04-30) — Interest Income: 545000.00
SKIL income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 545000.00
SKIL cash_flow (quarterly, 2026-04-30) — Interest Paid Supplemental Data: 13237000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Invested Capital: 502752000.00
SKIL cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -3501000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Line Of Credit: 1000000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 568163000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 568163000.00
SKIL cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -3202000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Net Debt: 460005000.00
SKIL cash_flow (quarterly, 2026-04-30) — Net Foreign Currency Exchange Gain Loss: -179000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income: -43114000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -43114000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -18695000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income Discontinuous Operations: -24419000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -43114000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -18695000.00
SKIL cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -43114000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -43114000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Interest Income: -13203000.00
SKIL cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: -3202000.00
SKIL cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: -3202000.00
SKIL income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -13203000.00
SKIL cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -425000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: -619118000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 35829000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Revenue: 1117000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 34712000.00
SKIL income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 27511000.00
SKIL income_statement (quarterly, 2026-04-30) — Normalized Income: -18637400.00
SKIL cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 28940000.00
SKIL cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: 14179000.00
SKIL income_statement (quarterly, 2026-04-30) — Operating Income: -6958000.00
SKIL income_statement (quarterly, 2026-04-30) — Operating Revenue: 94498000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 8835651.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 38176000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Current Borrowings: 6404000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Current Liabilities: 39229000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: -14587000.00
SKIL income_statement (quarterly, 2026-04-30) — Other Gand A: 4679000.00
SKIL income_statement (quarterly, 2026-04-30) — Other Income Expense: 2510000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Intangible Assets: 258653000.00
SKIL cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 1000000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 19697000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 7923000.00
SKIL income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: 2606000.00
SKIL income_statement (quarterly, 2026-04-30) — Other Operating Expenses: 3073000.00
SKIL income_statement (quarterly, 2026-04-30) — Other Taxes: 283000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Payables: 9056000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 23643000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 22336000.00
SKIL income_statement (quarterly, 2026-04-30) — Pretax Income: -17651000.00
SKIL cash_flow (quarterly, 2026-04-30) — Proceeds From Stock Option Exercised: -114000.00
SKIL cash_flow (quarterly, 2026-04-30) — Provisionand Write Offof Assets: -16000.00
SKIL cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -425000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Receivables: 77313000.00
SKIL income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 14132000.00
SKIL income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 31318000.00
SKIL cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: -3202000.00
SKIL income_statement (quarterly, 2026-04-30) — Research And Development: 13052000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Restricted Cash: 2811000.00
SKIL income_statement (quarterly, 2026-04-30) — Restructuring And Mergern Acquisition: 1341000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -1626324000.00
SKIL income_statement (quarterly, 2026-04-30) — Salaries And Wages: 30225000.00
SKIL income_statement (quarterly, 2026-04-30) — Selling And Marketing Expense: 4209000.00
SKIL income_statement (quarterly, 2026-04-30) — Selling General And Administration: 39598000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Share Issued: 9135428.00
SKIL income_statement (quarterly, 2026-04-30) — Special Income Charges: -1341000.00
SKIL cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 2842000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: -72815000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: -619118000.00
SKIL income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: -38400.00
SKIL income_statement (quarterly, 2026-04-30) — Tax Provision: 1044000.00
SKIL income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.40
SKIL balance_sheet (quarterly, 2026-04-30) — Total Assets: 853011000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 495348000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Total Debt: 575567000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: -72815000.00
SKIL income_statement (quarterly, 2026-04-30) — Total Expenses: 101456000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 925826000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 566000000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 611915000.00
SKIL income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: -8299000.00
SKIL income_statement (quarterly, 2026-04-30) — Total Unusual Items: -96000.00
SKIL income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: -96000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Treasury Shares Number: 299777.00
SKIL balance_sheet (quarterly, 2026-04-30) — Treasury Stock: 10891000.00
SKIL balance_sheet (quarterly, 2026-04-30) — Working Capital: -26901000.00
SKIN cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -15616000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Account Payable: 10523000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Accrued Expense: 24784000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: -594000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -6129000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -1393000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Payable: 9929000.00
SKIN cash_flow (annual, 2021-12-31) — Change In Tax Payable: -594000.00
SKIN balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 93816000.00
SKIN cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
SKIN cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 1700000.00
SKIN cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -22896000.00
SKIN cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
SKIN cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 781000.00
SKIN cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
SKIN balance_sheet (annual, 2021-12-31) — Other Payable: 2153000.00
SKIN balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
SKIN balance_sheet (annual, 2021-12-31) — Prepaid Assets: 12322000.00
SKIN cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 188378000.00
SKIN cash_flow (annual, 2021-12-31) — Purchase Of Business: -22896000.00
SKIN cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 5000000.00
SKIN cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -5000000.00
SKIN income_statement (annual, 2022-12-31) — +Operating Expense: 274620000.00
SKIN income_statement (annual, 2022-12-31) — +Total Revenue: 365876000.00
SKIN balance_sheet (annual, 2022-12-31) — Accounts Payable: 28467000.00
SKIN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 76494000.00
SKIN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -12494000.00
SKIN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 550320000.00
SKIN balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2929000.00
SKIN cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 15709000.00
SKIN cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 15709000.00
SKIN cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 5144000.00
SKIN income_statement (annual, 2022-12-31) — Average Dilution Earnings: -78343000.00
SKIN income_statement (annual, 2022-12-31) — Basic Average Shares: 147554090.00
SKIN income_statement (annual, 2022-12-31) — Basic EPS: 0.30
SKIN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 901886000.00
SKIN cash_flow (annual, 2022-12-31) — Capital Expenditure: -17394000.00
SKIN cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -17394000.00
SKIN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 17647000.00
SKIN balance_sheet (annual, 2022-12-31) — Capital Stock: 14000.00
SKIN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 568197000.00
SKIN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 568197000.00
SKIN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -205242000.00
SKIN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -18869000.00
SKIN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -106600000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Account Payable: 1606000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -3357000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 198000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Inventory: -84363000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -8045000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -4033000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -12078000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Payable: 1804000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -2954000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -13847000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Receivables: -32025000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Tax Payable: 198000.00
SKIN cash_flow (annual, 2022-12-31) — Change In Working Capital: -145267000.00
SKIN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -32025000.00
SKIN cash_flow (annual, 2022-12-31) — Changes In Cash: -330711000.00
SKIN balance_sheet (annual, 2022-12-31) — Common Stock: 14000.00
SKIN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 167053000.00
SKIN cash_flow (annual, 2022-12-31) — Common Stock Payments: -160000000.00
SKIN balance_sheet (annual, 2022-12-31) — Construction In Progress: 1375000.00
SKIN income_statement (annual, 2022-12-31) — Cost Of Revenue: 117097000.00
SKIN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 18983000.00
SKIN balance_sheet (annual, 2022-12-31) — Current Assets: 783275000.00
SKIN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 4958000.00
SKIN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4958000.00
SKIN balance_sheet (annual, 2022-12-31) — Current Liabilities: 71714000.00
SKIN cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1787000.00
SKIN cash_flow (annual, 2022-12-31) — Deferred Tax: -1787000.00
SKIN cash_flow (annual, 2022-12-31) — Depreciation: 7164000.00
SKIN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 22873000.00
SKIN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 22873000.00
SKIN balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 15473000.00
SKIN income_statement (annual, 2022-12-31) — Diluted Average Shares: 148506312.00
SKIN income_statement (annual, 2022-12-31) — Diluted EPS: 0.23
SKIN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -34119000.00
SKIN income_statement (annual, 2022-12-31) — EBIT: 58731000.00
SKIN income_statement (annual, 2022-12-31) — EBITDA: 81604000.00
SKIN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -2978000.00
SKIN cash_flow (annual, 2022-12-31) — End Cash Position: 568197000.00
SKIN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -205242000.00
SKIN balance_sheet (annual, 2022-12-31) — Finished Goods: 71283000.00
SKIN cash_flow (annual, 2022-12-31) — Free Cash Flow: -123994000.00
SKIN cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -78343000.00
SKIN cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 5239000.00
SKIN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 77047000.00
SKIN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -4530000.00
SKIN income_statement (annual, 2022-12-31) — General And Administrative Expense: 106100000.00
SKIN balance_sheet (annual, 2022-12-31) — Goodwill: 124593000.00
SKIN balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 170979000.00
SKIN balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 79423000.00
SKIN balance_sheet (annual, 2022-12-31) — Gross PPE: 46315000.00
SKIN income_statement (annual, 2022-12-31) — Gross Profit: 248779000.00
SKIN balance_sheet (annual, 2022-12-31) — Income Tax Payable: 1429000.00
SKIN income_statement (annual, 2022-12-31) — Interest Expense: 13392000.00
SKIN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 13392000.00
SKIN income_statement (annual, 2022-12-31) — Interest Income: 9175000.00
SKIN income_statement (annual, 2022-12-31) — Interest Income Non Operating: 9175000.00
SKIN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 9818000.00
SKIN balance_sheet (annual, 2022-12-31) — Interest Payable: 2344000.00
SKIN balance_sheet (annual, 2022-12-31) — Inventory: 109656000.00
SKIN balance_sheet (annual, 2022-12-31) — Invested Capital: 901196000.00
SKIN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -18869000.00
SKIN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
SKIN balance_sheet (annual, 2022-12-31) — Leases: 11812000.00
SKIN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 12689000.00
SKIN balance_sheet (annual, 2022-12-31) — Long Term Debt: 734143000.00
SKIN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 746832000.00
SKIN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
SKIN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
SKIN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 16853000.00
SKIN cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
SKIN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -160000000.00
SKIN balance_sheet (annual, 2022-12-31) — Net Debt: 165946000.00
SKIN cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 2410000.00
SKIN income_statement (annual, 2022-12-31) — Net Income: 44224000.00
SKIN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 44224000.00
SKIN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 44224000.00
SKIN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 44224000.00
SKIN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 44224000.00
SKIN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 44224000.00
SKIN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 44224000.00
SKIN cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -6547000.00
SKIN income_statement (annual, 2022-12-31) — Net Interest Income: -4217000.00
SKIN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
SKIN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
SKIN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -4217000.00
SKIN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -45242000.00
SKIN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1475000.00
SKIN balance_sheet (annual, 2022-12-31) — Net PPE: 33821000.00
SKIN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -10847000.00
SKIN cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
SKIN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -3926000.00
SKIN balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 815000.00
SKIN balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 2011000.00
SKIN balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 815000.00
SKIN balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2011000.00
SKIN income_statement (annual, 2022-12-31) — Normalized EBITDA: 4557000.00
SKIN income_statement (annual, 2022-12-31) — Normalized Income: -30973872.00
SKIN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -106600000.00
SKIN cash_flow (annual, 2022-12-31) — Operating Gains Losses: -78343000.00
SKIN income_statement (annual, 2022-12-31) — Operating Income: -25841000.00
SKIN income_statement (annual, 2022-12-31) — Operating Revenue: 365876000.00
SKIN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 132214695.00
SKIN balance_sheet (annual, 2022-12-31) — Other Current Assets: 27648000.00
SKIN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -4530000.00
SKIN income_statement (annual, 2022-12-31) — Other Gand A: 106100000.00
SKIN income_statement (annual, 2022-12-31) — Other Income Expense: 75397000.00
SKIN balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 46386000.00
SKIN cash_flow (annual, 2022-12-31) — Other Non Cash Items: 16439000.00
SKIN balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 14193000.00
SKIN balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 15473000.00
SKIN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1650000.00
SKIN balance_sheet (annual, 2022-12-31) — Other Payable: 1819000.00
SKIN balance_sheet (annual, 2022-12-31) — Other Properties: 16275000.00
SKIN balance_sheet (annual, 2022-12-31) — Payables: 42130000.00
SKIN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 61113000.00
SKIN balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5643000.00
SKIN balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
SKIN income_statement (annual, 2022-12-31) — Pretax Income: 45339000.00
SKIN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
SKIN balance_sheet (annual, 2022-12-31) — Properties: 0.00
SKIN cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 1622000.00
SKIN cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
SKIN cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -6547000.00
SKIN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -10847000.00
SKIN balance_sheet (annual, 2022-12-31) — Raw Materials: 38373000.00
SKIN balance_sheet (annual, 2022-12-31) — Receivables: 77774000.00
SKIN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 117097000.00
SKIN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 22873000.00
SKIN cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
SKIN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -160000000.00
SKIN income_statement (annual, 2022-12-31) — Research And Development: 8444000.00
SKIN balance_sheet (annual, 2022-12-31) — Retained Earnings: -378751000.00
SKIN income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 160076000.00
SKIN income_statement (annual, 2022-12-31) — Selling General And Administration: 266176000.00
SKIN balance_sheet (annual, 2022-12-31) — Share Issued: 132214695.00
SKIN cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
SKIN cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
SKIN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 28495000.00
SKIN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 167053000.00
SKIN balance_sheet (annual, 2022-12-31) — Tangible Book Value: -3926000.00
SKIN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 1849128.00
SKIN income_statement (annual, 2022-12-31) — Tax Provision: 1115000.00
SKIN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.02
SKIN balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1280000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Assets: 1003083000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Capitalization: 901196000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Debt: 751790000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 167053000.00
SKIN income_statement (annual, 2022-12-31) — Total Expenses: 391717000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 836030000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 219808000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 764316000.00
SKIN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -25841000.00
SKIN balance_sheet (annual, 2022-12-31) — Total Tax Payable: 11844000.00
SKIN income_statement (annual, 2022-12-31) — Total Unusual Items: 77047000.00
SKIN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 77047000.00
SKIN balance_sheet (annual, 2022-12-31) — Working Capital: 711561000.00
SKIN income_statement (annual, 2023-12-31) — +Operating Expense: 286030000.00
SKIN income_statement (annual, 2023-12-31) — +Total Revenue: 397991000.00
SKIN balance_sheet (annual, 2023-12-31) — Accounts Payable: 44768000.00
SKIN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 54697000.00
SKIN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -19953000.00
SKIN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 541281000.00
SKIN balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -6604000.00
SKIN cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 23343000.00
SKIN cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 23343000.00
SKIN cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 37840000.00
SKIN income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
SKIN income_statement (annual, 2023-12-31) — Basic Average Shares: 131680605.00
SKIN income_statement (annual, 2023-12-31) — Basic EPS: -0.76
SKIN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 568197000.00
SKIN cash_flow (annual, 2023-12-31) — Capital Expenditure: -13049000.00
SKIN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 13917000.00
SKIN balance_sheet (annual, 2023-12-31) — Capital Stock: 12000.00
SKIN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 523025000.00
SKIN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 523025000.00
SKIN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -37448000.00
SKIN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -31507000.00
SKIN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 21750000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Account Payable: 15783000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 26936000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 1282000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Inventory: -22617000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -7597000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Payable: 17065000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 44001000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -6951000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Receivables: 16520000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Tax Payable: 1282000.00
SKIN cash_flow (annual, 2023-12-31) — Change In Working Capital: 23356000.00
SKIN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 16520000.00
SKIN cash_flow (annual, 2023-12-31) — Changes In Cash: -47205000.00
SKIN balance_sheet (annual, 2023-12-31) — Common Stock: 12000.00
SKIN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 59390000.00
SKIN cash_flow (annual, 2023-12-31) — Common Stock Payments: -32395000.00
SKIN balance_sheet (annual, 2023-12-31) — Construction In Progress: 748000.00
SKIN income_statement (annual, 2023-12-31) — Cost Of Revenue: 242878000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 21990000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Assets: 698252000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4598000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4598000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 450000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 450000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Liabilities: 115008000.00
SKIN balance_sheet (annual, 2023-12-31) — Current Provisions: 21009000.00
SKIN cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1079000.00
SKIN cash_flow (annual, 2023-12-31) — Deferred Tax: -1079000.00
SKIN cash_flow (annual, 2023-12-31) — Depreciation: 11332000.00
SKIN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 34675000.00
SKIN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 34675000.00
SKIN balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 3555000.00
SKIN income_statement (annual, 2023-12-31) — Diluted Average Shares: 131680605.00
SKIN income_statement (annual, 2023-12-31) — Diluted EPS: -0.76
SKIN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -100116000.00
SKIN income_statement (annual, 2023-12-31) — EBIT: -88240000.00
SKIN income_statement (annual, 2023-12-31) — EBITDA: -53565000.00
SKIN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2033000.00
SKIN cash_flow (annual, 2023-12-31) — End Cash Position: 523025000.00
SKIN cash_flow (annual, 2023-12-31) — Financing Cash Flow: -37448000.00
SKIN balance_sheet (annual, 2023-12-31) — Finished Goods: 66915000.00
SKIN cash_flow (annual, 2023-12-31) — Free Cash Flow: 8701000.00
SKIN cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -11919000.00
SKIN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 14304000.00
SKIN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -3036000.00
SKIN income_statement (annual, 2023-12-31) — General And Administrative Expense: 131432000.00
SKIN balance_sheet (annual, 2023-12-31) — Goodwill: 125818000.00
SKIN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 187941000.00
SKIN balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 61301000.00
SKIN balance_sheet (annual, 2023-12-31) — Gross PPE: 46299000.00
SKIN income_statement (annual, 2023-12-31) — Gross Profit: 155113000.00
SKIN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2269000.00
SKIN balance_sheet (annual, 2023-12-31) — Income Tax Payable: 2759000.00
SKIN income_statement (annual, 2023-12-31) — Interest Expense: 13649000.00
SKIN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 13649000.00
SKIN income_statement (annual, 2023-12-31) — Interest Income: 23173000.00
SKIN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 23173000.00
SKIN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 9375000.00
SKIN balance_sheet (annual, 2023-12-31) — Interest Payable: 2344000.00
SKIN balance_sheet (annual, 2023-12-31) — Inventory: 91321000.00
SKIN balance_sheet (annual, 2023-12-31) — Invested Capital: 797762000.00
SKIN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -31507000.00
SKIN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
SKIN balance_sheet (annual, 2023-12-31) — Leases: 12323000.00
SKIN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 9319000.00
SKIN balance_sheet (annual, 2023-12-31) — Long Term Debt: 738372000.00
SKIN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 747691000.00
SKIN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
SKIN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
SKIN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 20221000.00
SKIN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
SKIN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -32395000.00
SKIN balance_sheet (annual, 2023-12-31) — Net Debt: 215347000.00
SKIN income_statement (annual, 2023-12-31) — Net Income: -100116000.00
SKIN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -100116000.00
SKIN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -100116000.00
SKIN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -100116000.00
SKIN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -100116000.00
SKIN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -100116000.00
SKIN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -100116000.00
SKIN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -9224000.00
SKIN income_statement (annual, 2023-12-31) — Net Interest Income: 9524000.00
SKIN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
SKIN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
SKIN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 9524000.00
SKIN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -5053000.00
SKIN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -18458000.00
SKIN balance_sheet (annual, 2023-12-31) — Net PPE: 26346000.00
SKIN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -3825000.00
SKIN cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
SKIN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -128551000.00
SKIN balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 531000.00
SKIN balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 702000.00
SKIN balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 531000.00
SKIN balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 702000.00
SKIN income_statement (annual, 2023-12-31) — Normalized EBITDA: -67869000.00
SKIN income_statement (annual, 2023-12-31) — Normalized Income: -114171091.95
SKIN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 21750000.00
SKIN cash_flow (annual, 2023-12-31) — Operating Gains Losses: -11919000.00
SKIN income_statement (annual, 2023-12-31) — Operating Income: -130917000.00
SKIN income_statement (annual, 2023-12-31) — Operating Revenue: 397991000.00
SKIN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 122899002.00
SKIN balance_sheet (annual, 2023-12-31) — Other Current Assets: 28877000.00
SKIN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -3036000.00
SKIN income_statement (annual, 2023-12-31) — Other Gand A: 131432000.00
SKIN income_statement (annual, 2023-12-31) — Other Income Expense: 19504000.00
SKIN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 62123000.00
SKIN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 11296000.00
SKIN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 16043000.00
SKIN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 2767000.00
SKIN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 5200000.00
SKIN balance_sheet (annual, 2023-12-31) — Other Properties: 13007000.00
SKIN balance_sheet (annual, 2023-12-31) — Payables: 62956000.00
SKIN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 84946000.00
SKIN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4005000.00
SKIN income_statement (annual, 2023-12-31) — Pretax Income: -101889000.00
SKIN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
SKIN balance_sheet (annual, 2023-12-31) — Properties: 0.00
SKIN cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 5153000.00
SKIN cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
SKIN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -9224000.00
SKIN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -3825000.00
SKIN balance_sheet (annual, 2023-12-31) — Raw Materials: 24406000.00